• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的体内、体外及药理学模型

In vivo, in vitro and pharmacologic models of Parkinson's disease.

作者信息

Salari S, Bagheri M

机构信息

Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran.

出版信息

Physiol Res. 2019 Mar 6;68(1):17-24. doi: 10.33549/physiolres.933895. Epub 2018 Oct 23.

DOI:10.33549/physiolres.933895
PMID:30433804
Abstract

Parkinson's disease (PD), which is the second most common neurodegenerative disorder after Alzheimer's disease, is firstly defined after James Parkinson's report. It carries motor symptoms such as resting tremor, bradykinesia and rigidity of skeletal muscle and freezing of gait. Furthermore, non-motor symptoms such as cognitive and behavioral problems, besides sensory impairments are seen in the patients. However, they may also suffer from sleep disorders or autonomic dysfunction. Although there are some medications in order to symptomatic management, but unfortunately, scientist could not have found exact approaches to cure this disease. Hence, producing a model which can express the most pathophysiologic and behavioral aspects of the disease is a desire. In this paper, we aimed to describe the different models of Parkinson's disease in brief.

摘要

帕金森病(PD)是仅次于阿尔茨海默病的第二常见神经退行性疾病,它首先在詹姆斯·帕金森的报告之后被定义。它具有运动症状,如静止性震颤、运动迟缓、骨骼肌僵硬和步态冻结。此外,患者还会出现认知和行为问题等非运动症状以及感觉障碍。然而,他们也可能患有睡眠障碍或自主神经功能障碍。尽管有一些药物用于对症治疗,但不幸的是,科学家尚未找到治愈这种疾病的确切方法。因此,建立一个能够表达该疾病最主要病理生理和行为方面的模型是人们所期望的。在本文中,我们旨在简要描述帕金森病的不同模型。

相似文献

1
In vivo, in vitro and pharmacologic models of Parkinson's disease.帕金森病的体内、体外及药理学模型
Physiol Res. 2019 Mar 6;68(1):17-24. doi: 10.33549/physiolres.933895. Epub 2018 Oct 23.
2
Animal models of Parkinson's disease.帕金森病动物模型。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5. doi: 10.1016/S1353-8020(11)70057-8.
3
Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP.使用6-羟基多巴胺和MPTP模型的帕金森病神经保护策略
Ann N Y Acad Sci. 2000;899:262-73. doi: 10.1111/j.1749-6632.2000.tb06192.x.
4
Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.SIRT5在MPTP诱导的帕金森病小鼠模型中对运动功能障碍和多巴胺能神经元变性的保护作用。
Behav Brain Res. 2015 Mar 15;281:215-21. doi: 10.1016/j.bbr.2014.12.035. Epub 2014 Dec 23.
5
Validity of the MPTP-Treated Mouse as a Model for Parkinson's Disease.经1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理的小鼠作为帕金森病模型的有效性。
Mol Neurobiol. 2016 Apr;53(3):1625-1636. doi: 10.1007/s12035-015-9103-8. Epub 2015 Feb 13.
6
Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.绘制帕金森病非人灵长类模型中帕金森样运动和非运动症状的发病图谱。
PLoS One. 2018 Aug 23;13(8):e0202770. doi: 10.1371/journal.pone.0202770. eCollection 2018.
7
Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.针对MPTP神经毒性和帕金森病中的活性氧、活性氮及炎症反应
Neurol Sci. 2008 Oct;29(5):293-301. doi: 10.1007/s10072-008-0986-2. Epub 2008 Oct 21.
8
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.可溶性环氧化物水解酶在帕金森病的发病机制中起关键作用。
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5815-E5823. doi: 10.1073/pnas.1802179115. Epub 2018 May 7.
9
Parkinson's disease: Autoimmunity and neuroinflammation.帕金森病:自身免疫与神经炎症。
Autoimmun Rev. 2016 Oct;15(10):1005-11. doi: 10.1016/j.autrev.2016.07.022. Epub 2016 Aug 4.
10
Application of neurotoxin- and pesticide-induced animal models of Parkinson's disease in the evaluation of new drug delivery systems.神经毒素和农药诱导的帕金森病动物模型在新型药物递送系统评估中的应用。
Acta Pharm. 2021 Aug 30;72(1):35-58. doi: 10.2478/acph-2022-0008. Print 2022 Mar 1.

引用本文的文献

1
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.帕金森病中的神经退行性变模型:神经元死亡的细胞和分子途径。
Behav Brain Funct. 2025 May 31;21(1):14. doi: 10.1186/s12993-025-00279-w.
2
NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease.NOSH-阿司匹林(NBS-1120)可减轻帕金森病大鼠模型的运动缺陷和多巴胺能神经元变性。
Eur J Pharmacol. 2025 Sep 5;1002:177733. doi: 10.1016/j.ejphar.2025.177733. Epub 2025 May 28.
3
Peptide Fraction from Snake Venom Showed Neuroprotection Against Oxidative Stress in Hippocampal mHippoE-18 Cells but Not in Neuronal PC12 Cells.
蛇毒中的肽组分对海马mHippoE - 18细胞的氧化应激具有神经保护作用,但对神经元PC12细胞则没有。
Antioxidants (Basel). 2025 Feb 26;14(3):277. doi: 10.3390/antiox14030277.
4
Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress.神经退行性疾病与儿茶素:(-)-表没食子儿茶素-3-没食子酸酯是慢性神经炎症和氧化应激的调节剂。
Front Nutr. 2024 Aug 1;11:1425839. doi: 10.3389/fnut.2024.1425839. eCollection 2024.
5
Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons.麦角硫因对人诱导多能干细胞衍生的多巴胺能神经元的神经保护作用
Antioxidants (Basel). 2024 Jun 5;13(6):693. doi: 10.3390/antiox13060693.
6
Rotenone-induced PINK1/Parkin-mediated mitophagy: establishing a silkworm model for Parkinson's disease potential.鱼藤酮诱导的PINK1/Parkin介导的线粒体自噬:建立帕金森病潜在的家蚕模型。
Front Mol Neurosci. 2024 Apr 19;17:1359294. doi: 10.3389/fnmol.2024.1359294. eCollection 2024.
7
Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease.研究一种抗炎药物在确定NURR1表达中的作用,从而探索帕金森病的进展。
Physiol Res. 2024 Mar 11;73(1):139-155. doi: 10.33549/physiolres.935168.
8
Comparative study of bilateral putamen for patients with severe Parkinson's disease detected by H magnetic resonance spectroscopy.采用氢磁共振波谱对重度帕金森病患者双侧壳核的对比研究。
Quant Imaging Med Surg. 2023 Oct 1;13(10):6646-6655. doi: 10.21037/qims-23-231. Epub 2023 Aug 22.
9
Luteolin Protects Against 6-Hydoroxydopamine-Induced Cell Death via an Upregulation of HRD1 and SEL1L.木犀草素通过上调 HRD1 和 SEL1L 来防止 6-羟多巴胺诱导的细胞死亡。
Neurochem Res. 2024 Jan;49(1):117-128. doi: 10.1007/s11064-023-04019-2. Epub 2023 Aug 26.
10
Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.青蒿素通过激活 ERK1/2 通路在体外和体内发挥对 6-OHDA 诱导的神经元损伤的神经保护作用。
Molecules. 2023 Jul 20;28(14):5527. doi: 10.3390/molecules28145527.